KMT2A and medulloblastoma: MiR-193a not only targeted MAX but several proliferation-related genes like CCND1, E2F1, STMN1, and chromatin modifier gene KMT2A that brought about widespread repression of gene expression in the MYC amplified Group 3 medulloblastoma cells.